ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01354691
Recruitment Status : Completed
First Posted : May 17, 2011
Last Update Posted : July 23, 2013
Sponsor:
Information provided by (Responsible Party):
Avraham Pharmaceuticals Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2012
  Actual Study Completion Date : March 2013